Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.63% | 35.09 | 0.9% | $1197.25m | |
| JNJ | Johnson & Johnson | -0.21% | 131.25 | 0.7% | $859.25m | |
| MRK | Merck & Co., Inc. | -0.18% | 86.75 | 0.6% | $783.59m | |
| ABBV | AbbVie, Inc. | -0.04% | 67.51 | 2.3% | $640.39m | |
| BMY | Bristol-Myers Squibb Company | 0.15% | 47.84 | 1.4% | $636.07m | |
| LLY | Eli Lilly and Company | 0.10% | 111.57 | 1.0% | $423.54m | |
| AZN | AstraZeneca PLC Sponsored ADR | 0.02% | 45.43 | 1.2% | $175.47m | |
| NVS | Novartis AG Sponsored ADR | -1.24% | 89.00 | 0.2% | $174.32m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | 0.71% | 40.98 | 0.3% | $96.41m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | 1.70% | 52.70 | 0.1% | $74.69m | |
| SNY | Sanofi Sponsored ADR | -1.46% | 42.57 | 0.2% | $48.72m | |
| LCI | Lannett Company, Inc. | -2.56% | 6.84 | 36.6% | $4.66m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | -4.81% | 1.78 | 1.6% | $3.40m | |
| EPIX | ESSA Pharma Inc | -5.26% | 1.80 | 0.1% | $0.04m |
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.